AMH and COVID-19: By adopting as the primary outcome, in women of reproductive age between 18 and 42years, the change in AMH levels three months after the first COVID-19 vaccine, minusthe initial AMH levels (AMH Delta), considering variations greater and less than10%, a prospective study also found no significant differences (Mohr-Sasson et al., 2022).